Tizanidine
Product Images NDC 10544-576

5 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 10544-576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

Chemical-structure (Image 01)
Chemical structure of tizanidine hydrochloride, showing its heterocyclic rings with chlorine and sulfur atoms, and an attached pyrrolidine ring.*
FDA Label Image

Figure-1 (Image 02)

Figure-1 (Image 02)
A line graph depicting plasma concentration of tizanidine (ng/mL) over 24 hours post-dosing. Four lines compare tablets and capsules, each with 4 mg doses taken with or without food. The graph shows concentration peaks around 1-2 hours, followed by a decline to near zero by 24 hours.*
FDA Label Image

Post-dose (Image 03)

Post-dose (Image 03)
A line graph depicting the improvement in Ashworth Score over six hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis shows improvement scores, and the x-axis indicates hours after dosing, illustrating greater improvement for both tizanidine dosages compared to placebo.*
FDA Label Image

Ashworth-score (Image 04)

Ashworth-score (Image 04)
A line graph comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups across three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Data points include mean values with error bars indicating variability.*
FDA Label Image

Label Graphic- Tizanidine (apotex) 4mg 30s (Image 05)

Label Graphic- Tizanidine (apotex) 4mg 30s (Image 05)
Tizanidine Tablets, USP 4mg, bottle label from Blenheim Pharmacal, Inc. The label indicates a 30-tablet count with NDC 10544-576-30. The label includes storage instructions, dosing directions to see the package insert, packaging details, lot number, expiration date placeholders, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.